Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer.


Ozaslan E., Topaloglu U. S., Inanc M., Gokmen Erdem U., Demir H., Arpaci E., ...Daha Fazla

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, cilt.22, sa.4, ss.863-868, 2017 (SCI-Expanded) identifier identifier